603259 药明康德
交易中 07-10 14:11:42
资讯
新帖
简况
大行评级丨大和：大幅上调药明康德目标价至190港元，列为中国CXO行业首选股之一
格隆汇 · 07-08 10:42
大行评级丨大和：大幅上调药明康德目标价至190港元，列为中国CXO行业首选股之一
每周股票复盘：药明康德（603259）回购A股用于员工持股计划
证券之星 · 07-05
每周股票复盘：药明康德（603259）回购A股用于员工持股计划
药明康德（603259）披露股份回购及可转债相关情况，7月3日股价上涨2.32%
证券之星 · 07-03
药明康德（603259）披露股份回购及可转债相关情况，7月3日股价上涨2.32%
【特约大V】邓声兴：美第三季度开局不利，恒指或随外围走低
金吾财讯 · 07-02
【特约大V】邓声兴：美第三季度开局不利，恒指或随外围走低
药明康德（603259）披露关于更换公司秘书的议案，7月1日股价上涨0.55%
证券之星 · 07-01
药明康德（603259）披露关于更换公司秘书的议案，7月1日股价上涨0.55%
药明康德：第四届董事会第四次会议决议公告
证券日报 · 07-01
药明康德：第四届董事会第四次会议决议公告
药明康德(02359)：杨小慧获委任为公司秘书及法律程序文件代理人
智通财经 · 07-01
药明康德(02359)：杨小慧获委任为公司秘书及法律程序文件代理人
摩根大通对药明康德H股空头头寸增至3.03%
美股速递 · 06-30
摩根大通对药明康德H股空头头寸增至3.03%
药明康德：已启动并顺利完成了A股股份回购工作
证券之星 · 06-30
药明康德：已启动并顺利完成了A股股份回购工作
大摩：升药明康德(02359)目标价至168港元 重申首选股
智通财经 · 06-30
大摩：升药明康德(02359)目标价至168港元 重申首选股
药明康德：两项股票回购工作均已实施完毕
证券之星 · 06-29
药明康德：两项股票回购工作均已实施完毕
6月29日药明康德涨6.76%，医药ETF易方达基金重仓该股
证券之星 · 06-29
6月29日药明康德涨6.76%，医药ETF易方达基金重仓该股
国金证券：给予药明康德买入评级，目标价146.03元
证券之星 · 06-29
国金证券：给予药明康德买入评级，目标价146.03元
药明康德完成10亿元股份回购计划；可孚医疗：拟斥资1亿元至2亿元回购公司A股股份｜医药早参
每日经济新闻 · 06-29
药明康德完成10亿元股份回购计划；可孚医疗：拟斥资1亿元至2亿元回购公司A股股份｜医药早参
股市必读：6月26日药明康德现6381.72万元大宗交易
证券之星 · 06-29
股市必读：6月26日药明康德现6381.72万元大宗交易
每周股票复盘：药明康德（603259）完成10亿股份回购
证券之星 · 06-28
每周股票复盘：药明康德（603259）完成10亿股份回购
药明康德（603259）披露A股股份回购进展，6月26日股价上涨0.82%
证券之星 · 06-26
药明康德（603259）披露A股股份回购进展，6月26日股价上涨0.82%
药明康德已回购970万股 金额10亿元
财中社 · 06-26
药明康德已回购970万股 金额10亿元
药明康德（603259）披露回购A股进展，6月25日股价上涨1.58%
证券之星 · 06-25
药明康德（603259）披露回购A股进展，6月25日股价上涨1.58%
药明康德(02359)6月25日斥资9996.94万元回购85.87万股A股
智通财经 · 06-25
药明康德(02359)6月25日斥资9996.94万元回购85.87万股A股
暂无数据
公司概况
公司名称：
无锡药明康德新药开发股份有限公司
所属行业：
研究和试验发展
上市日期：
2018-05-08
主营业务：
无锡药明康德新药开发股份有限公司的主营业务是为全球医药及生命科学行业提供一体化、端到端的新药研发和生产服务。公司的主要产品是化学业务、测试业务、生物学业务、其他业务。
发行价格：
21.60
{"stockData":{"symbol":"603259","market":"SH","secType":"STK","nameCN":"药明康德","latestPrice":124.08,"timestamp":1783663902000,"preClose":121.07,"halted":0,"volume":58651773,"delay":0,"changeRate":0.0249,"floatShares":2473000000,"shares":2984000000,"eps":6.7466,"marketStatus":"交易中","change":3.01,"latestTime":"07-10 14:11:42","open":120,"high":126.73,"low":120,"amount":7278000000,"amplitude":0.0556,"askPrice":124.07,"askSize":2,"bidPrice":124.06,"bidSize":39,"shortable":0,"etf":0,"ttmEps":6.7466,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1783666800000},"marketStatusCode":2,"adr":0,"adjPreClose":121.07,"symbolType":"stock","openAndCloseTimeList":[[1783647000000,1783654200000],[1783659600000,1783666800000]],"highLimit":133.18,"lowLimit":108.96,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":2983757155,"isCdr":false,"pbRate":4.29,"roa":"--","peRate":18.391486,"roe":"5.68%","epsLYR":6.7,"committee":0.401274,"marketValue":370225000000,"turnoverRate":0.0237,"status":0,"hkstockBrief":{"symbol":"02359","market":"HK","secType":"STK","nameCN":"药明康德","latestPrice":156.6,"timestamp":1783663899196,"preClose":149,"halted":0,"volume":4826281,"delay":0,"premium":"+9.20"},"floatMarketCap":306885000000},"requestUrl":"/m/hq/s/603259/tweets","defaultTab":"tweets","newsList":[{"id":"2649495485","title":"大行评级丨大和：大幅上调药明康德目标价至190港元，列为中国CXO行业首选股之一","url":"https://stock-news.laohu8.com/highlight/detail?id=2649495485","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649495485?lang=zh_cn&edition=full","pubTime":"2026-07-08 10:42","pubTimestamp":1783478522,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1997245177.USD","LU0611395673.USD","LU0708995583.HKD","BK1583","LU1997244956.HKD","LU2495084118.USD","LU2488822045.USD","IE00BPRC5H50.USD","LU2125910500.SGD","LU2242644610.SGD","LU1808992512.USD","LU2328871848.SGD","LU1770034418.SGD","603259","02359","LU1969619763.USD","BK0216","BK1141","LU0348766576.USD","LU1934453819.USD","BK1576","LU1719994722.HKD","LU0348767384.USD","LU2045819591.USD","LU1046422090.SGD","IE00B543WZ88.USD","LU1979443071.USD","LU1997245094.SGD","LU0320764599.SGD","LU0052750758.USD","LU0456842615.SGD","IE00B5MMRT66.SGD","LU1303224171.USD","LU1251922891.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649213691","title":"每周股票复盘：药明康德（603259）回购A股用于员工持股计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2649213691","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649213691?lang=zh_cn&edition=full","pubTime":"2026-07-05 01:06","pubTimestamp":1783184772,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，药明康德报收于124.12元，较上周的118.18元上涨5.03%。本周，药明康德7月2日盘中最高价报129.15元，股价触及近一年最高点。药明康德当前最新总市值3703.44亿元，在医疗服务板块市值排名1/51，在两市A股市值排名40/5203。股本股东变化：期内回购16,187,300股H股及9,701,1231股A股，A股回购用于员工持股计划。H股公告显示，截至2026年6月30日，公司H股和A股的法定注册资本无变动，总注册资本为人民币2,983,757,155元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500000093.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0348767384.USD","02359","LU2045819591.USD","LU1770034418.SGD","LU2242644610.SGD","IE00B5MMRT66.SGD","BK1141","LU0611395673.USD","603259","LU1979443071.USD","LU1251922891.USD","LU0348766576.USD","LU1303224171.USD","BK1576","LU1808992512.USD","LU2495084118.USD","BK0216","LU0320764599.SGD","IE00BPRC5H50.USD","399300","159982","LU0708995583.HKD","LU1969619763.USD","LU1997245177.USD","LU1997245094.SGD","LU1934453819.USD","LU1997244956.HKD","IE00B543WZ88.USD","LU2328871848.SGD","BK1583","LU0052750758.USD","LU2488822045.USD","LU1719994722.HKD","LU1046422090.SGD","LU0456842615.SGD","LU2125910500.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648317661","title":"药明康德（603259）披露股份回购及可转债相关情况，7月3日股价上涨2.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648317661","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648317661?lang=zh_cn&edition=full","pubTime":"2026-07-03 22:01","pubTimestamp":1783087311,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，药明康德报收于124.12元，较前一交易日上涨2.32%，最新总市值为3703.44亿元。该股当日开盘123.6元，最高125.06元，最低119.52元，成交额达87.54亿元，换手率为2.88%。近日，无锡药明康德新药开发股份有限公司披露证券变动月报表。截至2026年6月30日，公司H股和A股的法定注册资本无变动，总注册资本为人民币2,983,757,155元。期内，公司回购16,187,300股H股及9,701,231股A股，均作为库存股份持有。其中A股回购用于员工持股计划。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070300045096.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","LU0052750758.USD","IE00BPRC5H50.USD","02359","LU1934453819.USD","LU1969619763.USD","IE00B543WZ88.USD","LU1979443071.USD","LU2328871848.SGD","LU2242644610.SGD","LU1997245177.USD","LU1770034418.SGD","LU1997244956.HKD","LU2045819591.USD","BK1576","LU1808992512.USD","IE00B5MMRT66.SGD","LU0456842615.SGD","LU0348766576.USD","LU1997245094.SGD","LU1046422090.SGD","LU0320764599.SGD","LU0708995583.HKD","LU2125910500.SGD","LU0611395673.USD","LU1719994722.HKD","BK0216","LU2495084118.USD","LU1303224171.USD","BK1141","LU0348767384.USD","BK1583","LU1251922891.USD","603259"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648578018","title":"【特约大V】邓声兴：美第三季度开局不利，恒指或随外围走低","url":"https://stock-news.laohu8.com/highlight/detail?id=2648578018","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648578018?lang=zh_cn&edition=full","pubTime":"2026-07-02 09:45","pubTimestamp":1782956725,"startTime":"0","endTime":"0","summary":"国指跌47点或0.62%，报7558点。科指升79点或1.8%，报4472点。美第三季度开局不利，恒指或随外围走低。小分子D&M业务收入69.3亿元，按年激增80.1%，创单季历史新高；TIDES业务收入23.8亿元，客户数与服务分子数分别按年提升28%及59%，公司预计全年TIDES收入增长约40%。截至3月底，持续经营业务在手订单达597.7亿元，按年增长23.6%，为未来增长奠定坚实基础。考虑到公司CRDMO龙头地位、小分子D&M强劲增长及TIDES业务爆发潜力，估值仍具向上修复空间。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/NmQyMzI4NWZmMGRlNDRmMTg4YmIyOTUwMDI3OTAzODMzODA5NjYxNDI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NmQyMzI4NWZmMGRlNDRmMTg4YmIyOTUwMDI3OTAzODMzODA5NjYxNDI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1984931","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0052750758.USD","LU1046422090.SGD","LU2125910500.SGD","LU0708995583.HKD","BK1576","82800","03037","MCHmain","03419","BK1141","02833","06715","06915","HHImain","02697","LU2045819591.USD","09115","603259","HSTECH","02359","07500","07200","HSI","07300","BK1583","LU0320764599.SGD","LU2242644610.SGD","03952","83115","03115","LU0348767384.USD","LU0348766576.USD","513600","02800"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648549686","title":"药明康德（603259）披露关于更换公司秘书的议案，7月1日股价上涨0.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648549686","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648549686?lang=zh_cn&edition=full","pubTime":"2026-07-01 22:02","pubTimestamp":1782914539,"startTime":"0","endTime":"0","summary":"截至2026年7月1日收盘，药明康德报收于125.2元，较前一交易日上涨0.55%，最新总市值为3735.66亿元。该股当日开盘123.0元，最高126.66元，最低115.58元，成交额达135.55亿元，换手率为4.55%。近日，无锡药明康德新药开发股份有限公司披露第四届董事会第四次会议决议公告。会议审议通过《关于更换公司秘书的议案》，表决结果为11票赞成，0票反对，0票弃权。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100043234.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["IE00B5MMRT66.SGD","LU2328871848.SGD","603259","IE00B543WZ88.USD","IE00BPRC5H50.USD","LU0348767384.USD","LU1808992512.USD","LU1997245094.SGD","LU0456842615.SGD","LU1251922891.USD","BK0216","LU0611395673.USD","LU1997245177.USD","LU2242644610.SGD","BK1576","LU1770034418.SGD","LU0052750758.USD","LU1303224171.USD","LU2125910500.SGD","LU0320764599.SGD","LU2488822045.USD","LU1979443071.USD","LU2045819591.USD","BK1583","LU1046422090.SGD","LU1719994722.HKD","BK1141","LU1969619763.USD","02359","LU0708995583.HKD","LU2495084118.USD","LU1934453819.USD","LU1997244956.HKD","LU0348766576.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648548925","title":"药明康德：第四届董事会第四次会议决议公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2648548925","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648548925?lang=zh_cn&edition=full","pubTime":"2026-07-01 19:50","pubTimestamp":1782906600,"startTime":"0","endTime":"0","summary":"证券日报网讯7月1日，药明康德发布公告称，公司第四届董事会第四次会议审议通过《关于更换公司秘书的议案》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607013790452120.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0320764599.SGD","LU1046422090.SGD","02359","LU0456842615.SGD","LU2328871848.SGD","LU2125910500.SGD","BK1583","LU0708995583.HKD","LU0611395673.USD","LU2242644610.SGD","LU1997245177.USD","LU2488822045.USD","LU2495084118.USD","IE00B5MMRT66.SGD","BK1141","LU0348767384.USD","LU1719994722.HKD","LU2045819591.USD","LU1770034418.SGD","BK1576","LU1303224171.USD","LU1997245094.SGD","LU1979443071.USD","603259","BK0216","LU0052750758.USD","LU1251922891.USD","LU1808992512.USD","LU0348766576.USD","LU1969619763.USD","IE00B543WZ88.USD","LU1997244956.HKD","LU1934453819.USD","IE00BPRC5H50.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648251497","title":"药明康德(02359)：杨小慧获委任为公司秘书及法律程序文件代理人","url":"https://stock-news.laohu8.com/highlight/detail?id=2648251497","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648251497?lang=zh_cn&edition=full","pubTime":"2026-07-01 18:15","pubTimestamp":1782900948,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药明康德(02359)发布公告，卓佳专业商务有限公司(Vistra卓佳集团成员公司)公司秘书服务董事张月芬女士(张女士)已退休离任本公司其中一名公司秘书(公司秘书);及根据香港联合交易所有限公司证券上市规则第19A.13(2)条项下及香港法例第622章公司条例第16部在香港代表本公司接受送达法律程序文件及通知书的代理人(法律程序文件代理人)，自2026年7月1日起生效。本公司董事会进一步宣布，杨小慧女士(杨女士)已获委任接替张女士，自2026年7月1日起生效。其将与韩敏女士一起共同担任公司秘书及法律程序文件代理人，处理召集公司会议及秘书事务等日常公司治理事项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1461896.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1979443071.USD","LU1969619763.USD","LU2488822045.USD","LU2495084118.USD","LU0348767384.USD","LU1303224171.USD","LU1997244956.HKD","LU1997245177.USD","LU2045819591.USD","LU2328871848.SGD","LU0456842615.SGD","LU1770034418.SGD","IE00BPRC5H50.USD","LU0052750758.USD","BK1576","IE00B543WZ88.USD","LU2242644610.SGD","LU1997245094.SGD","BK0216","LU0611395673.USD","LU1046422090.SGD","IE00B5MMRT66.SGD","LU1934453819.USD","LU1251922891.USD","LU0708995583.HKD","BK1583","LU1719994722.HKD","LU1808992512.USD","02359","LU0320764599.SGD","LU0348766576.USD","BK1141","603259","LU2125910500.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134039316","title":"摩根大通对药明康德H股空头头寸增至3.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=1134039316","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134039316?lang=zh_cn&edition=full","pubTime":"2026-06-30 17:50","pubTimestamp":1782813046,"startTime":"0","endTime":"0","summary":"香港交易所数据显示，截至6月24日，摩根大通对药明康德H股的空头持仓比例已从之前的2.29%显著上升至3.03%。这一变动反映了市场参与者对该股后市走势的看空情绪有所加剧。空头头寸的增加通常意味着机构投资者预期股价可能下跌，并通过借入股票卖出的方式寻求获利。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1046422090.SGD","LU1969619763.USD","LU2125910500.SGD","LU2328871848.SGD","LU2488822045.USD","BK1576","LU0052750758.USD","LU0456842615.SGD","LU0348767384.USD","LU1770034418.SGD","LU2045819591.USD","LU1997245094.SGD","603259","IE00B543WZ88.USD","LU0348766576.USD","LU1719994722.HKD","LU1997244956.HKD","LU0320764599.SGD","02359","LU0708995583.HKD","LU2495084118.USD","LU2242644610.SGD","LU1997245177.USD","LU1251922891.USD","IE00BPRC5H50.USD","BK1583","LU1979443071.USD","LU1934453819.USD","LU1303224171.USD","LU1808992512.USD","BK1141","IE00B5MMRT66.SGD","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647395015","title":"药明康德：已启动并顺利完成了A股股份回购工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2647395015","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647395015?lang=zh_cn&edition=full","pubTime":"2026-06-30 17:03","pubTimestamp":1782810197,"startTime":"0","endTime":"0","summary":"证券之星消息，药明康德06月30日在投资者关系平台上答复投资者关心的问题。谢谢药明康德回复：您好，感谢您对公司的关注。截至目前，公司已启动并顺利完成了A股股份回购工作。除了通过股票回购保护股东权益外，公司坚信美国国防部依据1260H条款将公司列为“中国军工企业”的决定是错误的，缺乏事实与法律依据。公司已迅速启动法律程序，于6月11日在美国提起诉讼，正式请求法院撤销该决定并将公司从相关名单中移除。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000030769.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","LU1969619763.USD","IE00B543WZ88.USD","LU1251922891.USD","LU0320764599.SGD","LU1770034418.SGD","LU1997244956.HKD","LU2495084118.USD","LU1303224171.USD","LU0052750758.USD","399300","LU1934453819.USD","LU1808992512.USD","LU1046422090.SGD","LU0348766576.USD","LU1719994722.HKD","LU1979443071.USD","IE00BPRC5H50.USD","LU0456842615.SGD","LU1997245177.USD","603259","159982","LU0708995583.HKD","LU2328871848.SGD","LU2242644610.SGD","BK1576","LU0348767384.USD","BK1141","BK1583","IE00B5MMRT66.SGD","02359","LU1997245094.SGD","LU2125910500.SGD","LU2488822045.USD","LU2045819591.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647581810","title":"大摩：升药明康德(02359)目标价至168港元 重申首选股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647581810","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647581810?lang=zh_cn&edition=full","pubTime":"2026-06-30 10:58","pubTimestamp":1782788300,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，摩根士丹利发布研报称，将药明康德H股目标价由155港元上调至168港元，重申为其“首选股”，评级维持“增持”; 药明康德A股目标价亦由145元人民币上调至153元人民币，评级维持“增持”。摩根士丹利将药明康德2026至2028年的调整后盈利预测上调4%至6%，这意味着2025至2028年预测的年复合增长率达16%。该行预期药明康德的强劲表现将在2026年和2027年得以持续，且未来有可能会上调全年业绩指引。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1460970.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603259","02359","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647227793","title":"药明康德：两项股票回购工作均已实施完毕","url":"https://stock-news.laohu8.com/highlight/detail?id=2647227793","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647227793?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:57","pubTimestamp":1782723454,"startTime":"0","endTime":"0","summary":"证券之星消息，药明康德06月29日在投资者关系平台上答复投资者关心的问题。希望管理层加速回购进度，抓紧低位时段加大回购力度，展现公司对自身价值的认可，提振市场信心，请转交董事会。自5月起，公司已启动2026年度H股奖励信托计划下的H股购回工作。截至目前，两项股票回购工作均已实施完毕，具体请见相应公告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900025024.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["IE00B543WZ88.USD","LU2045819591.USD","LU0708995583.HKD","LU2242644610.SGD","BK1576","LU0320764599.SGD","LU2125910500.SGD","LU1997245177.USD","LU0348766576.USD","LU2495084118.USD","LU1979443071.USD","LU1969619763.USD","LU1934453819.USD","LU1251922891.USD","BK1141","LU2328871848.SGD","LU0052750758.USD","LU1997245094.SGD","LU1770034418.SGD","LU2488822045.USD","LU0348767384.USD","IE00B5MMRT66.SGD","LU1303224171.USD","LU1808992512.USD","603259","BK1583","LU1719994722.HKD","LU0456842615.SGD","LU1046422090.SGD","LU1997244956.HKD","BK0216","IE00BPRC5H50.USD","02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647324172","title":"6月29日药明康德涨6.76%，医药ETF易方达基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647324172","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647324172?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:32","pubTimestamp":1782721967,"startTime":"0","endTime":"0","summary":"证券之星消息，6月29日药明康德涨6.76%创60日新高，收盘报126.17元，换手率4.17%，成交量103.05万手，成交额127.44亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共629家，其中持有数量最多的公募基金为易方达基金的医药ETF易方达。医药ETF易方达目前规模为172.15亿元，最新净值0.3346，较上一交易日下跌1.88%，近一年下跌8.33%。医药ETF易方达的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900024269.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1997244956.HKD","LU0348767384.USD","BK1141","LU1303224171.USD","LU2488822045.USD","LU2495084118.USD","BK0216","LU2125910500.SGD","LU1969619763.USD","LU1808992512.USD","LU2045819591.USD","LU1046422090.SGD","IE00BPRC5H50.USD","LU1979443071.USD","512010","BK1583","LU0708995583.HKD","LU1997245177.USD","IE00B543WZ88.USD","LU1251922891.USD","LU1770034418.SGD","LU1719994722.HKD","LU0348766576.USD","LU0052750758.USD","LU2242644610.SGD","LU1934453819.USD","LU0320764599.SGD","02359","LU0456842615.SGD","LU1997245094.SGD","603259","LU2328871848.SGD","BK1576","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647411793","title":"国金证券：给予药明康德买入评级，目标价146.03元","url":"https://stock-news.laohu8.com/highlight/detail?id=2647411793","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647411793?lang=zh_cn&edition=full","pubTime":"2026-06-29 08:40","pubTimestamp":1782693633,"startTime":"0","endTime":"0","summary":"国金证券股份有限公司方程嫣,甘坛焕近期对药明康德进行研究并发布了研究报告《新分子业务快速放量，一体化CRDMO模式高筑行业护城河》，给予药明康德买入评级，目标价146.03元。我们认为，公司目前所处CDMO赛道正处于景气度加速上行阶段且公司Tides业务处于快速放量期，参考CDMO行业2026年28.5倍平均PE估值，考虑到公司行业龙头地位，给予2026年25XPE，目标价146.03元，首次覆盖，给予“买入”评级。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900002371.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603259","02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647349651","title":"药明康德完成10亿元股份回购计划；可孚医疗：拟斥资1亿元至2亿元回购公司A股股份｜医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2647349651","media":"每日经济新闻","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647349651?lang=zh_cn&edition=full","pubTime":"2026-06-29 07:00","pubTimestamp":1782687659,"startTime":"0","endTime":"0","summary":"丨2026年6月29日星期一丨NO.1药明康德：完成10亿元股份回购计划6月26日，药明康德公告称，公司已完成2026年股份回购计划，累计回购A股股份970.12万股，占总股本0.33%，实际回购金额10亿元，回购价格区间为95.11元/股至118.48元/股。回购股份将用于员工持股计划。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606293785660098.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606293785660098.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","IE00B543WZ88.USD","LU2045819591.USD","BK1161","LU0708995583.HKD","LU2242644610.SGD","BK1576","LU0320764599.SGD","LU2125910500.SGD","LU1997245177.USD","LU0348766576.USD","LU2495084118.USD","BK1100","LU1979443071.USD","LU1969619763.USD","LU1934453819.USD","LU1251922891.USD","BK1141","LU2328871848.SGD","LU0052750758.USD","LU1997245094.SGD","LU1770034418.SGD","BK1515","LU2488822045.USD","LU0348767384.USD","159982","IE00B5MMRT66.SGD","BK0251","LU1303224171.USD","LU1808992512.USD","603259","BK1583","LU1719994722.HKD","159938","LU0456842615.SGD","01187","LU1046422090.SGD","301087","LU1997244956.HKD","BK0216","09939","IE00BPRC5H50.USD","02359","399300"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647486243","title":"股市必读：6月26日药明康德现6381.72万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2647486243","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647486243?lang=zh_cn&edition=full","pubTime":"2026-06-29 01:35","pubTimestamp":1782668112,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，药明康德报收于118.18元，上涨0.82%，换手率2.77%，成交量68.49万手，成交额81.35亿元。当日关注点交易信息汇总：6月26日药明康德主力资金净流入4363.04万元。公司公告汇总：6月25日公司完成10亿元A股回购，实际回购9,701,231股，占总股本0.33%。公司公告汇总：6月25日公司以9996.94万元购回858,710股A股，用于员工持股计划，股份将持作库存股份。大宗交易6月26日药明康德发生6381.72万元大宗交易。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900000491.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1979443071.USD","LU1969619763.USD","LU2488822045.USD","LU2495084118.USD","LU0348767384.USD","LU1303224171.USD","LU1997244956.HKD","LU1997245177.USD","LU2045819591.USD","LU2328871848.SGD","LU0456842615.SGD","LU1770034418.SGD","IE00BPRC5H50.USD","LU0052750758.USD","BK1576","IE00B543WZ88.USD","LU2242644610.SGD","LU1997245094.SGD","BK0216","LU1046422090.SGD","IE00B5MMRT66.SGD","LU1934453819.USD","LU1251922891.USD","LU0708995583.HKD","BK1583","LU1719994722.HKD","LU1808992512.USD","02359","LU0320764599.SGD","LU0348766576.USD","BK1141","603259","LU2125910500.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646187083","title":"每周股票复盘：药明康德（603259）完成10亿股份回购","url":"https://stock-news.laohu8.com/highlight/detail?id=2646187083","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646187083?lang=zh_cn&edition=full","pubTime":"2026-06-28 01:48","pubTimestamp":1782582496,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，药明康德报收于118.18元，较上周的102.72元上涨15.05%。本周，药明康德6月26日盘中最高价报121.07元，股价触及近一年最高点。本周关注点来自交易信息汇总：6月23日药明康德发生1笔大宗交易，成交金额1.01亿元。来自公司公告汇总：药明康德于2026年6月25日完成股份回购，实际回购9,701,231股，使用资金超10亿元。本次购回股份拟用于员工持股计划，购回股份将持作库存股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062800000343.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0348766576.USD","LU1969619763.USD","LU1997245094.SGD","IE00B543WZ88.USD","LU2242644610.SGD","LU1303224171.USD","LU1934453819.USD","LU1979443071.USD","LU2045819591.USD","BK0216","LU0348767384.USD","LU2488822045.USD","LU2495084118.USD","LU1997245177.USD","LU2328871848.SGD","LU1770034418.SGD","BK1141","IE00B5MMRT66.SGD","LU0456842615.SGD","02359","LU0052750758.USD","LU0320764599.SGD","603259","IE00BPRC5H50.USD","BK1583","LU1046422090.SGD","LU1719994722.HKD","LU1808992512.USD","LU1997244956.HKD","BK1576","LU1251922891.USD","LU0708995583.HKD","LU2125910500.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646607355","title":"药明康德（603259）披露A股股份回购进展，6月26日股价上涨0.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646607355","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646607355?lang=zh_cn&edition=full","pubTime":"2026-06-26 17:47","pubTimestamp":1782467276,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，药明康德报收于118.18元，较前一交易日上涨0.82%，最新总市值为3526.2亿元。该股当日开盘119.0元，最高121.07元，最低116.96元，成交额达81.35亿元，换手率为2.77%。公司于近日披露A股股份回购进展：无锡药明康德新药开发股份有限公司于2026年6月25日在上海证券交易所购回A股股份858,710股，占当日已发行股份的0.0348%，支付总金额人民币99,969,385.8元，每股购回价介于人民币113.79元至118.48元之间。本次购回股份拟用于员工持股计划，购回股份将持作库存股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600032906.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2495084118.USD","LU1770034418.SGD","LU1303224171.USD","LU0348767384.USD","LU2242644610.SGD","399300","LU2328871848.SGD","LU0052750758.USD","LU2045819591.USD","LU1046422090.SGD","159982","LU1997245177.USD","BK1141","LU1251922891.USD","LU0348766576.USD","02359","IE00B543WZ88.USD","IE00B5MMRT66.SGD","IE00BPRC5H50.USD","BK1583","LU2125910500.SGD","LU2488822045.USD","BK1576","LU1934453819.USD","LU1719994722.HKD","LU0320764599.SGD","LU0708995583.HKD","LU1997244956.HKD","LU1979443071.USD","BK0216","LU1997245094.SGD","LU0456842615.SGD","LU1808992512.USD","603259","LU1969619763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646330463","title":"药明康德已回购970万股 金额10亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2646330463","media":"财中社","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646330463?lang=zh_cn&edition=full","pubTime":"2026-06-26 16:36","pubTimestamp":1782462960,"startTime":"0","endTime":"0","summary":"6月26日，药明康德（603259/02359）发布公告，截至2026年6月25日，公司已回购970万股，占总股本的0.33%，实际回购金额为10亿元，回购价格区间为95.11元/股至118.48元/股。2026年一季度，药明康德实现收入124.36亿元，归母净利润46.52亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606263784795775.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0320764599.SGD","LU2328871848.SGD","LU1997244956.HKD","BK1583","IE00B543WZ88.USD","LU1808992512.USD","LU0348767384.USD","BK0216","BK1141","LU1979443071.USD","LU1997245094.SGD","LU1934453819.USD","LU1997245177.USD","LU1303224171.USD","LU0708995583.HKD","02359","LU0052750758.USD","LU0456842615.SGD","LU2495084118.USD","603259","LU1046422090.SGD","BK1576","LU2488822045.USD","LU2242644610.SGD","LU2045819591.USD","LU2125910500.SGD","LU1770034418.SGD","LU1969619763.USD","LU1251922891.USD","LU0348766576.USD","IE00B5MMRT66.SGD","LU1719994722.HKD","IE00BPRC5H50.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646687613","title":"药明康德（603259）披露回购A股进展，6月25日股价上涨1.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646687613","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646687613?lang=zh_cn&edition=full","pubTime":"2026-06-25 17:30","pubTimestamp":1782379844,"startTime":"0","endTime":"0","summary":"截至2026年6月25日收盘，药明康德报收于117.22元，较前一交易日上涨1.58%，最新总市值为3497.56亿元。该股当日开盘114.0元，最高118.5元，最低113.23元，成交额达88.9亿元，换手率为3.09%。近日，无锡药明康德新药开发股份有限公司披露A股回购进展：公司于2026年6月24日购回870,140股A股，占当日已发行股份的0.0353%，每股购回价人民币108.29至116.88元，总代价约1.00亿元人民币。本次购回股份拟用于员工持股计划，并在上海证券交易所进行。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062500031759.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["IE00B5MMRT66.SGD","LU2328871848.SGD","603259","IE00B543WZ88.USD","IE00BPRC5H50.USD","LU0348767384.USD","LU1808992512.USD","LU1997245094.SGD","399300","LU0456842615.SGD","LU1251922891.USD","BK0216","LU1997245177.USD","LU2242644610.SGD","BK1576","LU1770034418.SGD","LU0052750758.USD","LU1303224171.USD","LU2125910500.SGD","LU0320764599.SGD","LU2488822045.USD","LU1979443071.USD","LU2045819591.USD","BK1583","LU1046422090.SGD","LU1719994722.HKD","159982","BK1141","02359","LU1969619763.USD","LU0708995583.HKD","LU2495084118.USD","LU1934453819.USD","LU1997244956.HKD","LU0348766576.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646873214","title":"药明康德(02359)6月25日斥资9996.94万元回购85.87万股A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2646873214","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646873214?lang=zh_cn&edition=full","pubTime":"2026-06-25 16:48","pubTimestamp":1782377293,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药明康德(02359)发布公告，于2026年6月25日斥资人民币9996.94万元回购85.87万股A股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1458667.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02359","LU2242644610.SGD","159982","LU2488822045.USD","IE00BPRC5H50.USD","IE00B5MMRT66.SGD","LU1934453819.USD","LU2045819591.USD","LU2125910500.SGD","LU1997244956.HKD","LU1997245177.USD","399300","BK1576","603259","LU1770034418.SGD","BK1583","LU0320764599.SGD","BK0216","LU0456842615.SGD","LU0708995583.HKD","LU1969619763.USD","LU1997245094.SGD","LU0348767384.USD","LU1046422090.SGD","LU2328871848.SGD","LU1979443071.USD","BK1141","LU1251922891.USD","IE00B543WZ88.USD","LU0052750758.USD","LU1719994722.HKD","LU1303224171.USD","LU2495084118.USD","LU0348766576.USD","LU1808992512.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1783663904539,"stockEarnings":[{"period":"1week","weight":-0.0019},{"period":"1month","weight":0.2951},{"period":"3month","weight":0.1567},{"period":"6month","weight":0.2414},{"period":"1year","weight":0.7705},{"period":"ytd","weight":0.357}],"compareEarnings":[{"period":"1week","weight":0.0019},{"period":"1month","weight":0.0066},{"period":"3month","weight":0.0126},{"period":"6month","weight":-0.0203},{"period":"1year","weight":0.1556},{"period":"ytd","weight":0.0171}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"无锡药明康德新药开发股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"285145人(较上一季度增加13.49%)","perCapita":"8673股","listingDate":"2018-05-08","address":"江苏省无锡市滨湖区马山五号桥","registeredCapital":"298375万元","survey":" 无锡药明康德新药开发股份有限公司的主营业务是为全球医药及生命科学行业提供一体化、端到端的新药研发和生产服务。公司的主要产品是化学业务、测试业务、生物学业务、其他业务。","listedPrice":21.6},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明康德(603259)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明康德(603259)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明康德,603259,药明康德股票,药明康德股票老虎,药明康德股票老虎国际,药明康德行情,药明康德股票行情,药明康德股价,药明康德股市,药明康德股票价格,药明康德股票交易,药明康德股票购买,药明康德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明康德(603259)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明康德(603259)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}